Target intelligence / Profile preview

High mobility group box 3 pseudogene 17 (HMGB3P17)

Target
HMGB3P17
Molecular classification
Pseudogene
01

Overview

High mobility group box 3 pseudogene 17 (HMGB3P17) is a transcribed human pseudogene representing a nonfunctional variant of the high mobility group box 3 gene. Pseudogenes are DNA sequences similar to functional genes but lack the ability to encode proteins due to mutations accumulated over evolution, including promoter loss, frameshift mutations, or premature stop codons[5][8][9]. HMGB3P17 may be transcribed under certain conditions and could participate in post-transcriptional gene regulation, such as acting as an RNA scaffold in developmental contexts or modulating RNA stability by competing for microRNAs or RNA-binding proteins[2][5]. It is not considered a conventional therapeutic target, nor are there described drugs, mechanisms, biomarkers, or safety concerns directly associated with this gene. Pseudogenes in general may be misannotated in large-scale genetic studies or complicate molecular diagnostics due to their sequence similarity to functional relatives[8][9].

Other names
HMGB3P17high mobility group box 3 pseudogene 17
02

Biological functions

Post-transcriptional regulation of gene expression (as a pseudogene, may act as a regulatory RNA)Possible involvement in developmental or tissue-specific gene expression programs
03

Disease associations

No direct clinical disease role is described for HMGB3P17, but some pseudogenes in the high mobility group box (HMGB) family may influence gene regulation in diseases indirectly.There is no evidence for direct therapeutic, biomarker, or pathological use of HMGB3P17.

Beyond the preview

Go deeper on High mobility group box 3 pseudogene 17 (HMGB3P17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 3 pseudogene 17 (HMGB3P17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call